Morgan Stanley
SVNT

Morgan Stanley’s SAVIENT PHARMACEUTICALS INC SVNT Stock Holding History

Morgan Stanley’s Portfolio SVNT Stock Details SVNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-219,110
Closed -$137K – 6453
2013
Q3 		$137K Sell
219,110
-46,365
-17% -$29.7K ﹤0.01% 5013
2013
Q2 		$149K Buy
+265,475
New +$185K ﹤0.01% 4970

Other funds holding SVNT

Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
FHC
First Heartland Consultants Lake St. Louis, Missouri $1.55B AUM 20.5% 1-Year Est. Return
PSC
Prentiss Smith & Co Brattleboro, Vermont $182M AUM 26.44% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Morgan Stanley's SVNT Position: Q4 2013 in Review

Morgan Stanley sold out of SAVIENT PHARMACEUTICALS INC (SVNT) in Q4 2013, closing a stake of 219,110 shares — an estimated $137K sold.

Morgan Stanley first reported a position in SVNT in Q2 2013 and held it in 2 quarters. The position peaked at $149K in Q2 2013. 7 funds tracked by Wall St. Rank hold SVNT as of Q4 2013.

  • Morgan Stanley reported no remaining SAVIENT PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Morgan Stanley sold 219,110 SAVIENT PHARMACEUTICALS INC shares in Q4 2013, an estimated $137K.
  • Morgan Stanley first reported a position in SAVIENT PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • Morgan Stanley's SAVIENT PHARMACEUTICALS INC position peaked at $149K in Q2 2013.
  • 7 funds tracked by Wall St. Rank held SAVIENT PHARMACEUTICALS INC as of Q4 2013.

Based on Morgan Stanley's 13F filing for Q4 2013, filed 13 Feb 2014.